Founded in
2016
SHORT DESCRIPTION:
NodThera is working on a novel family of NLRP3 inflammasome inhibitors that are both powerful and highly selective for the treatment of chronic inflammation-related disorders. We’re assembling a vibrant team of individuals in our Cambridge, UK, Seattle, WA, and Lexington, MA offices, all of whom are linked by a common sense of ambition, passion, and innovation.
LONG DESCRIPTION:
Little Chesterford
2016
$ 25+ Millions
Add a review